At the end of gastrulation in avians and mammals, the endoderm germ layer is an undetermined sheet of cells. Over the next 24-48 h, endoderm forms a primitive tube and becomes regionally specified along the anterior-posterior axis. Fgf4 is expressed in gastrulation and somite stage embryos in the vicinity of posterior endoderm that gives rise to the posterior gut. Moreover, the posterior endoderm adjacent to Fgf4-expressing mesoderm expresses the FGF-target genes Sprouty1 and 2 suggesting that endoderm respond to an FGF signal in vivo. Here, we report the first evidence suggesting that FGF4-mediated signaling is required for establishing gut tube domains along the A-P axis in vivo. At the gastrula stage, exposing endoderm to recombinant FGF4 protein results in an anterior shift in the Pdx1 and CdxB expression domains. These expression domains remain sensitive to FGF4 levels throughout early somite stages. Additionally, FGF4 represses the anterior endoderm markers Hex1 and Nkx2.1 and disrupts foregut morphogenesis. FGF signaling directly patterns endoderm and not via a secondary induction from another germ layer, as shown by expression of dominant-active FGFR1 specifically in endoderm, which results in ectopic anterior expression of Pdx1. Loss-of-function studies using the FGF receptor antagonist SU5402 demonstrate that FGF signaling is necessary for establishing midgut gene expression and for maintaining gene expression boundaries between the midgut and hindgut from gastrulation through somitogenesis. Moreover, FGF signaling in the primitive streak is necessary to restrict Hex1 expression to anterior endoderm. These data show that FGF signaling is critical for patterning the gut tube by promoting posterior and inhibiting anterior endoderm cell fate. q
Introduction
Defective endoderm development results in 3400 children/-year being born with congenital malformations of the gastrointestinal and respiratory tracts in the USA alone. In light of this, it is surprising how little is known about how early endoderm cells first obtain positional identity along the anterior-posterior (A-P) axis and how this regional identity is translated into defined organ boundaries for the esophagus, trachea, lungs, thyroid, thymus, stomach, liver, pancreas, duodenum, intestines, colon and uro-genital tract (Wells and Melton, 1999) . A better understanding of early endoderm development is a seminal first step in understanding congenital diseases of these organs (Johansson and Grapin-Botton, 2002; Wells, 2003) .
After gastrulation (e7.5), the mouse endoderm is a singlelayered sheet of approximately 500-1000 cells that are not yet specified along the A-P axis (Wells and Melton, 2000) and by e8.5-e9, endoderm has formed a primitive gut tube. The transformation of the endoderm sheet into a gut tube coincides with profound changes in gene expression patterns along the A-P axis. The e7.5 endoderm can be subdivided in broad anterior and posterior domains. In anterior endoderm, Hex1 (Hematopoietically expressed homeobox1), Cerberus and Foxa2 (Forkhead box A2) expression extend to, but do not overlap with the primitive streak (Ang and Rossant, 1994; Bouwmeester et al., 1996; Thomas et al., 1998) , suggesting that the primitive streak might function to limit gene expression boundaries. In posterior endoderm, Cdx2 (Caudal type homeobox 2) and 4 expressions are confined to cells overlying the primitive streak (Beck et al., 1995; Gamer and Wright, 1993) . By embryonic day e8.5, genes are expressed in defined, often mutually exclusive domains along the A-P axis of the developing gut tube. Genes such as Ttf1 (Thyroid transcription factor 1/Ttf1/Nkx2.1), Hex1, and Foxa2 are expressed in discrete foregut domains that contribute to the liver, lungs and thyroid. Pancreatic duodenal homeobox gene 1 (Pdx1) is expressed in the foregut/midgut boundary that gives rise to the pancreas and duodenum, whereas Cdx1, and 4 (Cdx A and B in chick) are expressed in the posterior midgut and hindgut that form the small and large intestines (Crompton et al., 1992; Ehrman and Yutzey, 2001; Ohlsson et al., 1993; Zeng et al., 1998) .
Numerous studies have identified soluble factors involved in later stages of endoderm organ specification. However, little is known about how endoderm is initially patterned along the A-P axis prior to formation of a gut tube in vivo. In vitro studies have shown that endoderm is patterned by instructive, soluble signals from the adjacent mesoderm between gastrulation and early somite stages (Kumar et al., 2003; Wells and Melton, 2000) . One factor, FGF4, patterns cultured e7.5 mouse endoderm in a concentration dependent manner. High concentrations of FGF4 promote a posterior/intestinal endoderm cell fate whereas lower concentrations of FGF4 induce a more anterior/pancreas-duodenal cell fate. The embryonic expression pattern of FGF4 at these stages of development is consistent with a role in patterning the posterior gut (Niswander and Martin, 1992; Shamim and Mason, 1999) , although this role for FGF4 has never been demonstrated in vivo. At the end of gastrulation, FGF4 is exclusively expressed in the posterior mesoderm and ectoderm adjacent to presumptive midgut and hindgut endoderm. Between gastrulation and early somite stages, FGF4 is expressed in discreet domains, with high persisting expression in the mesoderm adjacent to the developing midgut and hindgut and low, transient expression in the mesoderm adjacent to the presumptive posterior foregut/anterior midgut endoderm (Shamim and Mason, 1999) .
Due to the pre-gastrulation arrest of embryos lacking a functional Fgf4 gene (Feldman et al., 1995) , it has not been determined whether Fgf4 is necessary for mouse endoderm patterning in vivo. Ciruna et al. (1997) have shown that Fgfr1K/K ES cells fail to populate endoderm derivatives in mosaic embryos and it was therefore not possible to investigate the role of Fgfr1 in subsequent endoderm patterning. Studies in frog suggest that FGFs are involved in A-P patterning of ectoderm and mesoderm. Ectopic expression of FGFs in frog embryos causes an anterior expansion of posterior mesoderm and ectoderm markers. Conversely, blocking FGF signaling with dominant negative forms of the FGF receptor has the opposite effect of repressing posterior cell fate (Isaacs et al., 1998; Pownall et al., 1996; Ruiz i Altaba and Melton, 1989) . Studies in chick and mouse have also shown that FGF signaling is involved in posterior specification and patterning of mesoderm and ectoderm (Alvarez et al., 1998; Davidson et al., 2000; Storey et al., 1998) . In one example, FGF4 soaked beads grafted onto the anterior of gastrulation stage chick embryos resulted in ectopic expression of posterior neural markers in non-neural ectoderm (Alvarez et al., 1998) . FGF4 retained the ability to induce posterior neural markers in the anterior of mouse and chick embryos at somite stages (Bel-Vialar et al., 2002; Liu et al., 2001) . FGF4 beads grafted onto the anterior ectoderm of e7.5 mouse embryos repressed the anterior ectoderm markers Hesx1 and Six3, and suppressed forebrain morphogenesis (Davidson et al., 2000) . These reports show that FGF4 patterns the ectoderm and mesoderm, however it has not yet been demonstrated that FGF4 patterns the endoderm in vivo.
We have used gain-and loss-of-function studies in chick embryos to demonstrate that FGF signaling directly regulates endoderm and gut tube patterning in vivo. At late gastrulation stages FGF4 applied on beads induces an anterior shift in expression of the posterior gene CdxB and inhibits the expression of the anterior endoderm markers Hex1. These changes in early endoderm patterning result in an anterior shift of the posterior foregut marker Pdx1, loss of the ventral foregut marker Nkx2.1 and in extreme cases, disruption of foregut morphogenesis, suggesting that FGF4 promotes a posterior gut cell fate and represses anterior endoderm cell fate. At early somite stages, FGF4 retains the ability to regulate Pdx1 gene expression, but loses its ability to repress anterior endoderm development. Furthermore, expression of a constitutively activated FGF receptor specifically in endoderm induces anterior expression of Pdx1, demonstrating that effects of activated FGF signaling are directly on this germ layer. Inhibiting FGF signaling at late gastrulation stages with the chemical inhibitor SU5402 results in a posterior expansion of Hex1 expression and loss of Pdx1 expression; inhibiting FGF signaling at somite stages results in reduced anterior Pdx1 and CdxA expression and shifts caudal Pdx1 expression into the CdxA domain. This is the first evidence showing that FGF signaling is required for establishing and maintaining gut tube domains along the A-P axis in vivo.
Results

The expression domains of FGF4 and its target genes
Sprouty1 and 2 suggest a role for this ligand in posterior gut tube development.
At the end of gastrulation in mouse and chick, FGF4 is expressed in the mesoderm and ectoderm adjacent to the developing midgut and hindgut endoderm (Niswander and Martin, 1992; Shamim and Mason, 1999) Interestingly, between headfold and early somite stages FGF4 is transiently expressed at low levels in the paraxial mesoderm adjacent to the endoderm that gives rise to the posterior foregut/anterior midgut and strongly expressed adjacent to presumptive hindgut endoderm. We investigated whether the endoderm cells adjacent to the FGF4 expression domains are responding to an FGF signal by analyzing the expression of the FGFresponsive genes Sprouty1 and 2 (Chambers and Mason, 2000) (Fig. 1) . From late gastrulation stage (HH 4-5) to early somite stages (HH 8-10) (Hamburger and Hamilton, 1951; Schoenwolf et al., 1992) , Sprouty1 and 2 are expressed in the vicinity of Fgf4 domains (Fig. 1 ). Blue and black bars illustrate the published spatial domains and relative levels of Fgf4 expression in the mesoderm along the A-P axis (Shamim and Mason, 1999) . Although the temporal and spatial expression of Sprouty1 and 2 mirrors that of Fgf4, their expression extends more laterally. Importantly, Sprouty 1 (data not shown) and Sprouty 2 are expressed in the endoderm, the ventral most layer of cells (Fig. 1 , lower panels, high magnification arrows) suggesting that endoderm cells are responding to an FGF signal during gut tube patterning in vivo.
2.2. Exogenously applied FGF4 regulates early endoderm patterning along the A-P axis in vivo.
We have used chick embryos to study the consequences of altered FGF4 signaling levels on the patterning and development of the gut tube. We first determined that endoderm responds to exogenous FGF4 by grafting heparin agarose beads soaked in FGF4 (250 mg/ml) onto the anterior endoderm of stage HH3C chick embryos (mid primitive streak stage) in modified new cultures (Stern and Ireland, 1981) and assaying for the expression of Sprouty 1 and 2 at stage HH4-5 (Fig. 2) . Unlike control beads (PBS-soaked), FGF4-soaked beads induced ectopic expression of Sprouty 1 (Fig. 2A, 6 /10 embryos) and Sprouty 2 (Fig. 2B , 5/6 embryos) in a broad domain anterior and lateral to the primitive streak, suggesting that the FGF4 protein diffused away from the bead. This broad diffusion was not surprising because beads were grafted onto endoderm on the ventral side of the embryo, which is an open lumen allowing the FGF4 protein to freely diffuse over the endoderm. This approach was designed to limit the FGF4 exposure predominantly to endoderm. Analysis of sectioned embryos show that endogenous Sprouty 1 (nZ8) and Sprouty 2 (nZ16) were expressed in the mesoderm and endoderm adjacent to the primitive streak (Fig. 2 , black brackets) whereas expression in ectoderm extended anterior and lateral to the primitive streak. In FGF4 treated embryos, Sprouty 1 and 2 were ectopically induced in anterior mesendoderm ( Fig. 2A,B , red brackets). Since, ectoderm expressed endogenous Sprouty anterior to the primitive streak we could not determine whether the expression domain of Sprouty in the ectoderm is expanded in FGF4 treated embryos.
To determine the effects of FGF4 signaling on early endoderm patterning, embryos grafted at stage HH3C (Fig. 3 , upper panels) were collected at stage HH4-5 for analysis using Hex1 as an early marker of anterior endoderm (Yatskievych et al., 1999) and CdxB as an early posterior marker (Ehrman and Yutzey, 2001) . In FGF4 treated embryos, the Hex1 expression domain is reduced in size (Fig. 3A , 5/10 embryos) relative to the control embryos (nZ0/6), suggesting that anterior endoderm fate is repressed by FGF4. The fact that the steady state level of Hex1 mRNA was significantly reduced in only half of the embryos could be due to slow Hex1 mRNA turnover, since the embryos were collected only 5-6 h after bead-grafting. In the posterior, FGF4 beads (250 mg/ml) shifted the posterior limit of CdxB towards the anterior (black arrow) relative to the contralateral side, which had not been exposed to FGF4 (red arrow) (Fig. 3B , 5/8 embryos). Analysis of sectioned embryos showed that the anterior expansion of CdxB expression was in the definitive endoderm, mesoderm and in the area opaca. In the lower panel of Fig. 3B , the red arrows point to the endoderm of the FGF4 treated side and the black arrows point to the control side. These data suggest that FGF4 promotes posterior cell fate. This effect was not observed in any control embryos (nZ0/9).
To investigate how alterations of early patterning affect subsequent gut tube patterning and development, embryos were grafted with FGF4 beads at HH4 and analyzed at later stages when the gut tube is forming (HH10-12). Foregut morphogenesis was assessed morphologically and by expression of Foxa2, which is expressed throughout the foregut, and patterning was assessed by expression Nkx2.1 and Pdx1 (Fig. 4) . Formation of the foregut was repressed when FGF4 beads were grafted onto the axial endoderm anterior to the primitive streak (Fig. 4A , 42/ 51 by morphological analysis, 11/13 by analysis of Foxa2 expression). This suggests that inhibition of early anterior endoderm patterning (Fig. 3A) impacts the subsequent development of the foregut. The profound effects of axial placement of FGF4 beads on foregut development made analysis of foregut patterning problematic. We therefore grafted FGF4 beads laterally at stage HH4 to target presumptive ventral foregut endoderm and found that foregut folding was relatively normal in these embryos at stage HH11. However, expression of Nkx2.1 in the ventral foregut is reduced ( Fig. 4B -arrow, 5/7 embryos) confirming that anterior endoderm patterning is disrupted. We observed that FGF4 beads grafted after HH6 did not inhibit foregut development suggesting that the ability of FGF4 to inhibit anterior endoderm cell fate is restricted to pre-somitic stages (6/7 embryos, data not shown). Consistent with this, Hoxb-4, which is normally expressed in endoderm posterior to branchial arch four as well as in the other two germ layers, is not shifted anteriorly by FGF4 at stage HH10 confirming that foregut genes do not respond to FGF4 beyond gastrulation (6/6 embryos, data not shown).
We investigated how FGF4 impacts the patterning of the posterior foregut/anterior midgut with the marker Pdx1, which is exclusively expressed in the endoderm deriving the caudal stomach, duodenum and dorsal and ventral components of the pancreas. FGF4 beads were grafted anterior to the presumptive midgut/Pdx1 domain of stage HH4-5 embryos and this resulted in an anterior shift in the Pdx1 expression domain (dotted lines) relative to the somites (arrow heads) (6/10 embryos). In control embryos, the axial and lateral Pdx1 expression domains extend between somite 2-8 at stage HH10-11, whereas FGF4 embryos had Pdx1 expression anterior to somite 1 and extending to somite 6 (Fig. 4C , dotted lines). Taken together, these findings suggest that FGF4 patterns early endoderm by repressing anterior/foregut endoderm identity and promoting more posterior gut endoderm identity.
It is possible that other FGFs expressed in the primitive streak at this time also have endoderm patterning activity. We therefore determined whether FGF2 and FGF8b, like FGF4, could disrupt anterior endoderm patterning/foregut morphogenesis in vivo. Using morphological criteria described in the Materials and Methods we determined that FGF2 has approximately 50% the foregut inhibitory activity of FGF4, and FGF8b has virtually no activity ( Supplementary Fig. 1A ). We tested whether this was due to general activity differences between these FGF ligands and found that FGF2 had 2.8-fold more activity than FGF4 per milligram of protein as measured in an NIH-3T3 cell proliferation assay ( Supplementary Fig. 1A ). Therefore, when normalized for activity per mg of protein, FGF4 has up to 5-fold more endoderm patterning activity than FGF2 and up to 12-fold more than FGF8, suggesting that FGF4 has uniquely high endoderm patterning activity.
FGF4 regulation of A-P patterning of the Pdx1 domain persists at somitic stages
At the early somite stages, FGF4 is expressed at low levels in paraxial mesoderm adjacent to the presumptive Pdx1 domain (Shamim and Mason, 1999) . In addition, we previously demonstrated that the Pdx1 expression domain is still plastic at early somite stages (Kumar et al., 2003) . We therefore hypothesized that low levels of FGF4-mediated signaling continues to play a role in patterning the Pdx1 domain at these later stages in vivo. To study this we grafted FGF4 beads anterior to or into the Pdx1 domain between stages HH9 and 11 (5 to 12 somite-stage) and analyzed effects on expression 1-2 days later (stage HH 15 to HH 18-19) (Fig. 5) . Heparin beads soaked in high concentration of FGF4 (1 mg/ml) or control beads were grafted unilaterally and adjacent to the somites at different levels along the A-P axis either in lateral plate mesoderm or on endoderm. When FGF4-beads were placed anterior to the endogenous Pdx1 domain, we observed an . Arrows point to the anterior-lateral limit of CdxB expression on the FGF4-treated (black arrowhead) and the contralateral control side (red arrowhead). CdxB expression is shifted toward the anterior on the FGF4 side compared to the contralateral side. The bottom panel shows CdxB expression in a sectioned embryo, which is shifted anteriorly in definitive endoderm, mesoderm and the area opaca. Black arrows point to the endoderm of the FGF4 treated side and the red arrows point to the endoderm cells of the control side.
anterior expansion of Pdx1 expression toward the grafted bead (Fig. 5B, 3 /4 embryos), suggesting that increasing FGF4 signalling causes these cells to adopt a more posterior fate and express Pdx1. This effect that was never observed on the contralateral side or in control embryos grafted with beads soaked in PBS (4 embryos). FGF4 beads that were placed directly within the Pdx1 expression domain caused reduced Pdx1 expression (nZ3/4) (Fig. 5A ). This suggests that elevating the levels of FGF signalling within the Pdx1 domain is antagonistic to endoderm adopting Pdx1 cell fate. This effect A. HNF3b/Foxa2 expression in the foregut 1 day after bead grafting. Control embryos (PBS beadempty circle) had a well-developed foregut. Embryo grafted with FGF4 bead (250 mg/ml, empty circle) had no foregut tube. B. Nkx2.1 expression in the ventral foregut and forebrain 1 day after bead grafting. Control stage HH 11 embryos express Nkx2.1 in the ventral foregut (arrowhead) and in the anterior central nervous system (CNS red bracket). Stage HH4 embryos that had FGF4 beads grafted onto anterior-lateral endoderm that gives rise to the ventral foregut did not express Nkx2.1 in the foregut (arrowhead), although foregut morphogenesis was normal. Nkx2.1 expression in the anterior CNS (red brackets) was unaffected by FGF4. C. Pdx1 expression in the posterior foregut/anterior midgut 1 day after grafting. In control embryos (PBS beads, empty circle), Pdx1 is expressed in midline endoderm between somite 4 and 8, and in two lateral domains between somite 1 and 4 (dashed lines). The head is out of focus because the embryo is curved. In FGF4 bead grafted embryos (200 mg/ml, empty circle) the entire Pdx1 expression domain is shifted anterior relative to somite 1 and 8. The position of the bead prior to in situ hybridization is indicated by a circle. Beads are often lost during in situ hybridization. Arrowheads point to the position of somite 1 and 8.
was not observed on the contralateral side or with control beads (3 embryos). FGF4 beads induced the expression of the Sprouty1 and 2 in endoderm and mesoderm up to 200 mm away from the bead demonstrating the range of action of this ligand (nZ14/15, plus control beads nZ5/5, data not shown). These results show that endodermal cells are still competent to respond to changes in FGF4 levels at somitic stages and suggests that altering FGF4 signalling levels can modify the A-P gene expression patterns in endoderm.
Endoderm is a direct target of FGF-mediated signaling
In order to determine whether the effect of FGF4 on endoderm is direct, we introduced a dominant active (da) FGFR1 expression construct specifically into endoderm by electroporation (Fig. 6 ). Embryos were electroporated at stage HH4 and fixed 1 day later at stage HH11-13. Endoderm-specific expression was confirmed by co-electroporating a GFP-expressing vector and analysis of sectioned embryos showing expression in endoderm and not mesoderm (Fig. 6A,E ). Embryos electroporated with FGFR1 exhibited ectopic expression of Pdx1 anterior and lateral to its normal expression domain demonstrating that endoderm is a direct target of FGF signaling (Fig. 6B ,C, 6/9 embryos). The ectopic Pdx1 expression matched the domains targeted by electroporation, although only a subset of GFP-positive cells was Pdx1-positive. We have determined that this is likely due to the fact that the daFGFR1 protein was only expressed in w10% of the electroporated cells (Fig. 6E) . Although the reason for this is unknown it could be due to partial co-electroporation because the size of the daFGFR1-expression vector, which is three times larger, or due to delayed expression of the RCAS-based daFGFR1-expression vector (GFP is expressed as early as 3 h after electroporation but RCAS proteins take about 16 h to accumulate). Interestingly, electroporated cells located posterior to the Pdx1-expression domain never ectopically expressed Pdx1 suggesting that FGF posteriorizes cell identity. Electroporation with a control vector did not trigger anterior Pdx1 expression (0/8 embryos). These data demonstrate that endoderm is directly affected by FGF signaling.
FGF signaling is necessary for initiating and maintaining posterior endoderm patterning and for restricting anterior endoderm gene expression
To determine whether FGF signaling is required for endoderm patterning at late gastrulation and somitic stages, we used SU5402, to inhibit the tyrosine kinase activity of FGFR1 (Mohammadi et al., 1998; Mohammadi et al., 1997) . We investigated the role of FGF signaling in early endoderm patterning by grafting resin beads soaked in 1 or 10 mM of SU5402 or in PBS onto the endoderm immediately anterior to the primitive streak of HH3C embryos and analyzed expression of the anterior endoderm marker Hex1 after 5 h at HH5-6. Hex1 expression was both upregulated and shifted toward the posterior in SU5402 treated embryos (Fig. 7A , 12/16 embryos) relative to control embryos that were treated in parallel (0/9). The control embryos in Fig. 7 have less Hex1 staining than in Fig. 3 because the in situ substrate reaction was stopped early to prevent overdeveloping of the SU5402-treated embryos. SU5402 also caused a reduction of CdxB mRNA in the posterior, although this was only observed in 25% of the embryos (3/12 SU5402 treated, 0/6 control, data not shown). This may be due to the short 5-h treatment, since a reduction of CdxB mRNA as measured by in situ hybridization would require both inhibition of transcription and turnover of existing mRNA.
To investigate how early endoderm patterning defects affected subsequent gut tube patterning, we grafted SU5402 beads onto the prospective Pdx1 region at HH4 and analyzed Pdx1 expression after 24 h (HH10-12). Pdx1 expression was severely reduced in SU5402 treated embryos (Fig. 7B, 6 /9 SU5402 embryos, 0/6 control embryos). Analysis of sectioned embryos demonstrates that the notochord, dorsal aorta and lateral plate mesoderm, all of which have been shown to regulate Pdx1 expression (Kim et al., 1997; Kumar et al., 2003; Lammert et al., 2001) were phenotypically normal in SU5402 treated embryos (Fig. 7B lower panels) . Therefore, loss of Pdx1 expression was not likely due to a gross defect in development of one of these structures.
Our data shows that somite stage endoderm retains the ability to respond to FGF4. To determine if FGF signaling is necessary for midgut endoderm patterning at these stages, SU5402 beads were grafted in the lateral plate mesoderm between stages HH9 and 11 (5 to 12 somite-stage) and embryos were harvested after 1 or 2 days. The Pdx1 expression domain was affected in 11 out of 16 embryos receiving SU5402-soaked beads but never in embryos grafted with PBS-soaked beads (0/5) (Fig. 7C) . When the SU5402 beads were adjacent to the Pdx1 domain, they suppressed Pdx1 expression (nZ4 embryos) whereas beads grafted just posterior to the endogenous Pdx1 domain induced expression more posteriorly (nZ5) (Fig.7C ). These two results suggest that moderate levels of FGF signaling are needed to maintain expression of Pdx1 but high levels of FGF signaling in the posterior act to repress Pdx1 expression. In two embryos both effects were observed resulting in a posterior shift of the entire Pdx1 expression domain (data not shown). The repressive effect of SU5402 was also seen at a lower penetrance with the mid-hindgut marker CdxA (5/13) but not with control beads (3/3) (Fig. 7D) . No posterior shift could be observed since CdxA expression extends to the end of the tail. Anterior foregut does not appear to require FGF signaling for patterning as Hoxb-4 expression in branchial arch 4 and more posterior areas is not repressed by SU5402 (nZ6/6, data not shown). Together these data suggest that an FGF signal is required at somite stages to maintain A-P boundaries in the endoderm of the posterior fore-, mid-and hindgut.
Discussion
FGFs are required for endoderm patterning from gastrula to somite stages
Here, we report the first evidence suggesting that FGF4-mediated signaling is required for establishing and maintaining gene expression boundaries along the A-P axis of the developing gut tube in vivo. At the late gastrula stage the Fgf4 expression domain directly coincides with the presumptive mid and hindgut domains and abuts the presumptive foregut domain. At early somite stages, Fgf4 is expressed at low levels in the mesoderm adjacent to the posterior foregut/anterior midgut endoderm and high levels in the vicinity of the hindgut. Sprouty 1 and 2 are expressed in the endoderm adjacent to the Fgf4 expression domain throughout these stages, suggesting that endoderm is responding to endogenous Fgf4, and the expression these FGF-target genes is upregulated in endoderm in response to exogenous FGF4 protein. Gain-and loss-of-function experiments show that FGF signaling The endogenous Pdx1 expression is seen as two wings on each side of the embryo. Ectopic anterior expression of Pdx1 is highlighted in circled areas 1, 2, and 3. The most posterior circled area is out of focus. Lines in B show the plane of section in C and D where the ectopic and endogenous Pdx1 expression is in the endoderm. E. Expression of daFGFR1 protein (red) is seen in approximately 10% of the electroporated (nuclear GFP; green) cells. Cells that express both daFGFR1 and GFP have a yellow nucleus and red cytoplasm (arrow head). F. In control embryos electroporated with pCIG alone, only endogenous Pdx1 expression was observed G. Endoderm is shown facing up in whole mounts and sections.
represses anterior and promotes posterior endoderm fate and this activity is critical for patterning endoderm and establishing gut tube domains. The ability of FGF4 to regulate A-P gene expression boundaries of Pdx1 and CdxA persists at later somite stages, suggesting that FGF4 acts both to establish broad anterior-posterior boundaries and to maintain boundaries between the fore, mid and hindgut.
Our experiments suggest that endoderm is patterned by FGF4 in both a concentration and a temporal dependent manner. When additional FGF4 is applied between gastrulation and early somite stages, the local effect is the induction of a more posterior fate in endoderm cells (Pdx1 and CdxA) and a suppression of anterior endoderm cell fate (Hex1, Nkx2.1). Reduction of FGF signaling has the opposite effect: Anterior genes are expanded toward the posterior (Hex1) and more posterior gene expression is lost (Pdx1). At early somite stages, FGF4-mediated signaling has the same effect: additional FGF4 causes anterior endoderm to be posteriorized (Pdx1 expression shifted anteriorly) and a reduction of FGF signaling disrupts A-P gene expression boundaries (Pdx1 loss in fore/midgut, Pdx1 induction and CdxA loss in mid/hindgut). This late requirement for FGFs may be important with regards to gut tube formation. Indeed, as the anterior intestinal portal progresses, anterior tissues are progressively brought posteriorly and must therefore acquire the same A-P identity as overlying dorsal tissues that have not moved.
The ability of FGF signaling to repress anterior endoderm patterning is lost by late headfold stage (HH6) (data not shown). Remarkably, by early somite stages (HH8) FGF signaling via FGF2 expressed in cardiac mesoderm plays a role in patterning the ventral foregut endoderm into liver and lung domains (Deutsch et al., 2001; Gualdi et al., 1996; Serls et al., 2005) . This shows that within a few hours of development, anterior endoderm cells respond differently to FGF ligands, which could be due to changes in FGF receptor composition or activation of different downstream signaling pathways. It is also known that Hoxb4 expression cannot be shifted anteriorly by FGF4 at somite stages (HH10-11) and FGF is not required Fig. 7 . Antagonizing FGF signaling with SU5402 results in a posterior expansion of anterior endoderm patterning and disrupts midgut and hindgut endoderm patterning. A. Hex1 expression approximately 5 h after grafting SU5402-soaked beads anterior to the primitive streak at stage HH3C embryos. SU5402 beads (black or yellow circle) caused an upregulation and posterior expansion of Hex1 into the anterior primitive streak region, relative to control embryos. The control embryos in this figure have lighter Hex1 staining than in Fig. 3 because the BM purple color reaction was stopped early so that the SU5402-treated embryos did not overdevelop. B. Pdx1 expression 1 day after grafting of SU5402-soaked beads onto the presumptive midgut endoderm of stage HH four embryos. The SU5402 bead is highlighted by an empty circle. Pdx1 expression is reduced or absent in SU5402 treated embryos. Black line points to the plane of section shown in the lower panels after nuclear fast red counterstaining. Notochord (n), dorsal aortae (da), lateral plate mesoderm (lpm) and endoderm (e). C. Pdx1 expression 2 days after grafting SU5402-soaked beads into the lateral plate mesoderm of somite stage HH11 embryos. In control embryos both sides had the same anterior (A) and posterior (P) expression boundaries (black arrowheads point to posterior boundary). SU5402 beads next to the posterior limit of the Pdx1 domain caused a posterior shift in expression (empty arrowhead). After 2 days of incubation, the final position of the beads was anterior to initial grafting site accounting for effects observed caudally to the bead. D. CdxA expression 2 days after grafting SU5402-soaked beads into the lateral plate mesoderm of somite stage HH11 embryos. Black arrowheads show the normal anterior boundary of CdxA expression and empty arrowheads show the anterior boundary in SU5402 treated embryos. Whole mounts are presented ventral face up and the gut tube is largely closed except in the lower panel of B where the view is 45 degrees between ventral and lateral to show the two sides at the level of the AIP and the beads at the same time.
for Hoxb4 expression in the foregut at somite stages. The FGF4 expression domain shifts posteriorly over time, and the time of exposure to FGF4 could establish midgut and hindgut domains. For example, cells submitted to progressively more FGF4 with time might constantly reset their AP identity towards a more posterior one until they lose competence and the size of the midgut is defined. The involvement of FGF4 in progressively restricting CNS pattern has also been reported (Bel-Vialar et al., 2002) .
FGF4 patterns the three germ layers along the A-P axis
In addition to functioning in endoderm patterning, FGF4 controls A-P patterning in the neural tube and mesoderm of Vertebrates. In Xenopus bFGF has a concentration-dependent caudalizing effect on neurectoderm from late blastula/gastrula to somite stages (neurula) (Cox and Hemmati-Brivanlou, 1995; Harland and Lamb, 1995; Okamoto and Kengaku, 1995) . Evidence for posterior activation of endogenous FGF signaling in Xenopus was demonstrated by maintenance of MAP kinase activation, as measured by ERK phosphorylation (Schohl and Fagotto, 2002) . Chick FGF bead-grafting experiments and explant cultures have been used to demonstrate that FGFs can induce posterior markers in neural tube at gastrula and somite stages (Bel-Vialar et al., 2002; Laufer et al., 1997; Storey et al., 1998) . At somite stages, only markers posterior to Hoxb5 are shifted anteriorly by FGF4. It has been reported that the suppression of anterior genes by FGF is retinoic acid independent whereas activation of posterior genes is retinoic acid dependent (Kudoh et al., 2002) .
Loss-of-function studies have also implicated FGF signaling in mesoderm and ectoderm patterning. Over expression of a dominant negative FGF receptor in Xenopus and Zebrafish embryos blocks the formation of posterior structures including posterior mesoderm and neural tube (Amaya et al., 1991; Griffin et al., 1995; Stein et al., 1993) . Mutations of FGF receptor 1 in mouse embryos demonstrate a function of this receptor in posterior mesoderm formation and A-P patterning (Deng et al., 1994; Partanen et al., 1998; Yamaguchi et al., 1994) . Due to early endoderm defects in these experiments, the role of FGFR1 in endoderm patterning was not investigated. In chick, induction of posterior fates by gastrulation stage (stage HH4) paraxial mesoderm is blocked by SU5402 but SU5402 does not block the ability of stage HH7 paraxial mesoderm to induce Hoxb8 (Muhr et al., 1999) . In neural tube explants, SU5402 blocks the ability of the node to induce Hoxc8, c9 and c10. These data suggest that expression of posterior markers in the mesoderm and neural tube, like in the endoderm, may require a longer exposure to FGF4 as compared to expression of more anterior markers.
FGF4 signals directly to endoderm and has unique activity
As FGF4 is involved in patterning the three germ layers along the A-P axis, and due to their cross talk, it is important to establish which of its effects are direct. There is evidence that FGFs could have a direct action on ectoderm and mesoderm and that specific ligands differentially signal via different FGF receptors (Ornitz et al., 1996) . By introducing dominantactivated FGFR1 specifically in endoderm, we provide evidence that FGFs act directly on endoderm. However, it is possible that daFGFR1-expressing endoderm cells signal to adjacent endoderm cells, which then express ectopic Pdx1. In agreement with a direct effect of FGF4 in endoderm A-P patterning, Sprouty 1 and 2, direct targets of several FGF ligands, are induced in endoderm in response to FGF4 bead grafting. Moreover, FGF4 regulates expression of A-P markers in isolated cultured endoderm (Wells and Melton, 2000) . Nevertheless, our experiments do not rule out that in addition to a direct effect, FGF4 elicits indirect effects through other germ layers.
In addition to the unique expression pattern of FGF4 adjacent to developing posterior gut tube domains, we have found that FGF4 has unique endoderm patterning activity in vivo and in vitro compared to other FGF ligands expressed at these stages of development. For example, FGF4 has significant patterning activity on cultured endoderm explants when compared to FGF2, 5, 8 or 10 (Kumar et al., 2003; Wells and Melton, 2000) . Here, we show that FGF4 is unique in its endoderm patterning activity in vivo relative to FGF2 and 8b. It is not surprising that FGF4 activity is unique in the context of endoderm patterning, since Fgf4 K/K embryos arrest at the onset of gastrulation, demonstrating that other FGF ligands expressed at this time do not functionally substitute for FGF4.
It is not known which FGF receptor mediates the endoderm patterning activity of FGF4. FGF receptors 1, 2, 3 and 4 are expressed in endoderm between gastrula and somite stages, but expression of each subtype has not been reported (Eichmann et al., 1994; Korhonen et al., 1991; Marcelle et al., 1995; Stark et al., 1991; Walshe and Mason, 2000; Yamaguchi et al., 1992) . However, we have observed that FGF ligands, such as FGF4 that signal predominantly via FGFR1c and FGFR2c have endoderm patterning activity whereas FGF ligands that signal via FGFR4, such as FGF8, do not (Ornitz et al., 1996) . Mouse embryos that have a null mutation in the FGFR1 gene fail to gastrulate; therefore the functional involvement of FGFR1 during endoderm patterning has not been established (Deng et al., 1994; Yamaguchi et al., 1994) . Although subtle A-P shifts in gene expression have been observed in the mesoderm of FGFR1 hypomorphs, endoderm development and patterning in these embryos has not been analyzed (Partanen et al., 1998) . Endoderm patterning defects have not been reported in FGFR2 knockout animals which die shortly after implantation (Arman et al., 1998) or in hypomorphic animals which die at 11.5 dpc (Xu et al., 1998) . Furthermore, deletion of exon IIIc of FGFR2 leads to viable animals without any report of endoderm mispatterning (Eswarakumar et al., 2002) . FGF response elements that bind ETS transcription factors (downstream targets of FGFs) have been recently evidenced in Xcad3 (CdxB) promoter in Xenopus. CdxB may thus be a direct endoderm target of FGF signaling (Haremaki et al., 2003) .
Different FGFs endowed with different functions in the posterior foregut/anterior midgut
It was previously reported that low levels of FGF2 could induce expression of Pdx1 in cultured dorsal endoderm isolated from somite stage chick embryos (Hebrok et al., 1998) . In contrast, FGF2 did not induce expression of Pdx1 in cultured lateral endoderm that gives rise to the ventral component of the pancreas in chick (Kumar et al., 2003) . In fact, FGF2 repressed expression of Pdx1 in cultured ventral foregut endoderm isolated from mouse (Deutsch et al., 2001) . Our data are in agreement with the observation that FGF signaling regulates Pdx1 expression. However, our findings in vivo suggest that FGF4 has broad endodermal A-P patterning activity whereas the reported activity of FGF2 in vitro may be restricted to refine pattern in ventral foregut endoderm. For example, it was recently shown using ventral foregut explants that high levels of FGF2 promote lung fate and moderate levels promote liver cell fate (Serls et al., 2005) . This work also suggested that high concentrations of FGF2 (50 and 500 ng/ml) induced the lung marker Nkx2.1 in posterior endoderm explants suggesting that FGF2 has broad endoderm patterning activity. Although contradictory to our current and previous findings that FGF2 does not have broad endoderm patterning activity (Kumar et al., 2003; Wells and Melton, 2000) , this difference is likely due to the fact that at the low concentrations that we used (1-10 ng/ml), FGF4 has significantly higher patterning activity than FGF2 (Supplemental Fig. 1 ), but at higher concentrations, other FGF ligands can act in this manner. Physiologically, FGF2 is not expressed at the right time and place to be involved in broad endoderm patterning. It is possible that other FGF ligands that we have not investigated may be have broad endoderm patterning activity. For example FGF13 is expressed at these stages in an A-P gradient in LPM and posterior somites and FGF18 is expressed in the presomitic mesoderm (Karabagli et al., 2002) . It is not known if either of these ligands has the same activity as FGF4.
Our experiments demonstrate a vital role for FGF signaling in the global positioning of gut tube domains along the A-P axis and strongly argue that FGF4 is unique in its ability to establish these gut tube domains in vivo. However, the mechanism of action of FGF4 is still unclear. The regulation of FGF4 activity in the extracellular milieu and its target genes are still poorly understood. It has been proposed that FGF is a caudalizing factor because it maintains a state of competence in responsive cells that allow them to respond to other signals (Mathis et al., 2001) . Retinoic acid may be one of these other signals as it was recently shown that this compound controls endoderm A-P patterning in Zebrafish, Xenopus and chick (Chen et al., 2004; Kumar et al., 2003; Prince and Stafford, 2002) .
Experimental Procedures
Chick embryo isolation and culture
Fertilized White Leghorn chicken eggs (Charles River, MA) were incubated at 38 8C to obtain staged embryos (Hamburger and Hamilton, 1951) .
Chick embryos were isolated and placed in a modified New culture for in vitro manipulation (Chapman et al., 2001) . Briefly, eggs were placed into a 10 cm plate, and the albumen was scraped off of the embryonic region with a razor blade. A 15 by 15 mm piece of Watman paper #1 with a 5 mm hole in the center was placed over the embryo, and the embryo was cut away and placed ventral (endoderm) side up on an 0.8% agar plate containing 50% albumin, 0.3% glucose, 1x penn/strep in saline.
Application of FGFs
Recombinant FGF4, FGF2 and FGF8b were purchased from R&D Systems Inc. (Minneapolis, MN) . Heparin acrylic beads (Sigma) ranging from 150-250 mm in diameter were soaked in a solution of PBS with or without 50 ng-1 mg/ml FGF4. Such high concentrations are required when FGF4 is loaded on beads as it is inefficiently released (Cohn et al., 1995) . For gastrula stage engraftment, beads were cut in half and placed flat side down on endoderm being careful not to tear the endoderm. For somitic stage engraftment, beads were inserted underneath endoderm, in the lateral plate mesoderm immediately adjacent to somites at different levels along the A-P axis.
Application of SU5402
SU 5402 was purchased from Calbiochem. AG1-X2 anion exchange resin (BioRad) containing chloride bound beads ranging from 200-400 mm in diameter were equilibrated in formate for which they have a low affinity. Formate was then replaced by SU5402 at a concentration of 1 or 10 mM. Beads were placed on top of endoderm at gastrulation stages or at somite stages inserted underneath endoderm in the lateral plate mesoderm immediately adjacent to somites at different levels along the A-P axis. Control beads were soaked in PBS.
FGF activity assays
NIH3T3 cell proliferation assays were performed as per the manufacturers protocol (Roche). Briefly, 2000 cells were plated out in 98 well plates and grown overnight. Cells were serum starved for 24 h then media was replaced with serum free media containing the FGF ligand. After 48 h, cells were washed and the cell proliferation reagent, WST-1 was added. Substrate conversion, which measures the metabolic activity of the cells, was measured at A450 on a microplate reader. Replicate experiments were performed and for each experiment individual FGF concentrations were monitored in triplicate. These experiments showed that our stocks of FGFs were active (Supplemental Fig. 1) . We used the effects of different FGF ligands on foregut development as a rapid assay to monitor ligand activity on endoderm development. Four embryos were used for each dose of FGF ligand, and foregut development was measured on a scale of 0-3. Embryos with a normal foregut were scored 0, embryos that had mild delays in foregut morphogenesis were scored 1, embryos in which foregut morphogenesis was initiated but then arrested were scored 2, and embryos that had a completely open foregut were scored 3. As seen in Supplemental Fig. 1B, FGF4 at 25 ng/ml completely inhibited foregut morphogenesis in all four embryos and received a score of 12. To insure that endoderm was exposed to a relatively uniform concentration of FGFs, we pipetted 0.5 ml of a range of FGF dilutions (1, 10, 25 ng/ml diluted in PBS) directly onto anterior endoderm. For FGF4, this resulted in identical phenotypes as compared to grafting beads with high concentrations of FGF4 (250-500 ng/ml), but gave much more reproducible results within a narrow concentration range.
Electroporation of endoderm
Fertilized White Leghorn chicken eggs (Charles River, MA) were incubated at 38 8C to obtain stage HH4 embryos (Hamburger and Hamilton, 1951) . A hole was made in the shell on the side of the air chamber and a window was then cut on top of the egg. A solution of 2 mg/ml DNA in 1XPBS, 3 mg/ml carboxymethylcellulose and 50 mg/ml Nile Blue Sulfate was injected in the yolk under the embryo, in contact with ingressed endoderm and hypoblast. The DNA mix contained a plasmid in which GFP is driven by a CMV/b-actin promoter (pCIG) (Grapin-Botton et al., 2001) in control embryos and a 1:1 mix of this plasmid with a RIS (replication incompetent RCAS retrovirus) expressing a dominant-activated form of FGFR1 (Liu et al., 2001) . A negative tungsten electrode was inserted below the embryo and a positive electrode was held by a micromanipulator above the embryo, in a PBS drop. Three square pulses of 15 V and 50 ms were applied 1 s apart using a BTX T-830 electroporator (Genetronics). After electroporation, eggs were sealed with tape and incubated for 28-32 h. Embryos were dissected, photographed under a fluorescent stereomicroscope to reveal GFP, fixed in 4% formaldehyde in PBS and further processed for whole mount in situ hybridization.
In situ hybridization and sectioning of embryos
Whole mount in situ hybridization was performed as described previously (Wilkinson and Nieto, 1993) . Briefly, embryos were fixed, dehydrated in methanol, rehydrated, treated with 6% hydrogen peroxide, proteinase K treated for 1.5 min, and postfixed in 4% paraformaldehyde. Embryos were hybridized in buffer containing 1 mg/ml probe over night at 70 8C. Embryos were washed and incubated overnight with an anti digoxigenin antibody (1:1000). Embryos were developed with BM purple (Boehringer Mannheim) or NBT/BCIP. In situ hybridization probes were previously published: Pdx-1 (Kim et al., 1997) , CdxA (Frumkin et al., 1993) , CdxB (Ehrman and Yutzey, 2001 ) and Tbx5 (Gibson-Brown et al., 1998; Searcy and Yutzey, 1998) , Hex1 (Crompton et al., 1992) , Nkx2.1 (Zeng et al., 1998) , Sprouty 2 (Chambers and Mason, 2000) . The chick Sprouty 1 and HNF3b/Foxa2 probes were generated by RT-PCR amplification from stage HH8 chick cDNA. The primers used to amplify Sprouty 1 were: forward; 5 0 -tgctcttgctcccagtcacattgc-3 0 , reverse; 5 0 -gttgggtaaagccttacatccccc-3 0 . The primers used to amplify Foxa2 were:
Forward; 5 0 -ccgagcaccactacgcctt-3 0 , Reverse; 5 0 -cctccttgcgacaacgacaa-3 0 The cDNAs for Sprouty 1 and Foxa2 were cloned into pKSIIC(Stratagene). For histological analysis of sectioned embryos, 6 mm paraffin sections were dewaxed in xylene, rehydrated in PBS, and counter stained with nuclear fast red (Vector Laboratories, Burlingame, CA). Afterwards, slides were dehydrated and coverslipped with Permount (Fisher Scientific, PA).
